Atlas Trials

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Clinical trial NCT02042443 · COMPLETED

Trial details

NCT number
NCT02042443
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular CarcinomaBCLC Stage D Adult Hepatocellular CarcinomaHilar CholangiocarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver CarcinomaRecurrent Childhood Liver CancerRecurrent Extrahepatic Bile Duct CarcinomaRecurrent Gallbladder CarcinomaStage II Gallbladder CancerStage III Childhood Hepatocellular Carcinoma
Start date
2014-02-01
Primary completion
2017-01-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.